Smokeless cannabis delivery device efficient and less toxic

A smokeless cannabis-vaporizing device delivers the same level of active therapeutic chemical and produces the same biological effect as smoking cannabis, but without the harmful toxins, according to UCSF researchers.

Results of a UCSF study, which focuses on delivery of the active ingredient delta-9-tertrahydrocannibinol, or THC, are reported in the online issue of the journal Clinical Pharmacology and Therapeutics.

"We showed in a recent paper in the journal Neurology that smoked cannabis can alleviate the chronic pain caused by HIV-related neuropathy, but a concern was expressed that smoking cannabis was not safe. This study demonstrates an alternative method that gives patients the same effects and allows controlled dosing but without inhalation of the toxic products in smoke," said study lead author Donald I. Abrams, MD, UCSF professor of clinical medicine.

The research team looked at the effectiveness of a device that heats cannabis to a temperature between 180 and 200 degrees C, just short of combustion, which occurs at 230 degrees C. Eighteen individuals were enrolled as inpatients for six days under supervision in the General Clinical Research Center at San Francisco General Hospital Medical Center.

Under the study protocol, the participants received on different days three different strengths of cannabis by two delivery methods—smoking or vaporization—three times a day.

Plasma concentrations of THC were measured along with the exhaled levels of carbon monoxide, or CO. A toxic gas, CO served as a marker for the many other combustion-generated toxins inhaled when smoking. The plasma concentrations of THC were comparable at all strengths of cannabis between smoking and vaporization. Smoking increased CO levels as expected, but there was little or no increase in CO levels after inhaling from the vaporizer, according to Abrams.

"Using CO as an indicator, there was virtually no exposure to harmful combustion products using the vaporizing device. Since it replicates smoking’s efficiency at producing the desired THC effect using smaller amounts of the active ingredient as opposed to pill forms, this device has great potential for improving the therapeutic utility of THC," said study co-author Neal L. Benowitz, MD, UCSF professor of medicine, psychiatry and biopharmaceutical sciences. He added that pills tend to provide patients with more THC than they need for optimal therapeutic effect and increase side effects.

Patients rated the "high" they experienced from both smoking and vaporization and there was no difference between the two methods by patient self-report of the effect, according to study findings. In addition, patients were asked which method they preferred.

"By a significant majority, patients preferred vaporization to smoking, choosing the route of delivery with the fewest side effects and greatest efficiency," said Benowitz.

Source: University of California - San Francisco

Related stories:

Researchers look at cannabinoids, genes, medicines and brain scans to find better anxiety treatments
Right now, about half of all people who take medicine for an anxiety disorder don’t get much help from it. And doctors have no definitive way to predict who will, and who won’t, benefit from each anti-anxiety prescription they write.
Smoked cannabis proven effective in treating neuropathic pain
Smoked cannabis eased pain induced in healthy volunteers, according to a study by researchers at the University of California, San Diego (UCSD) Center for Medical Cannabis Research (CMCR.) However, the researchers found that less may be more.
Endogenous cannabinoids linked to fetal brain damage imposed by maternal cannabis use
A critical step in brain development is governed by endogenous cannabinoids, ‘the brain’s own marijuana’. Studies conducted at Swedish medical university Karolinska Institutet, with participation of scientists from Europe and the US, are now published in Science and show that these endogenous molecules regulate how certain nerve cells recognize each other and form connections. The scientists believe that their findings will significantly advance our understanding of how cannabis smoking during pregnancy may damage the fetal brain.
Cannabis less harmful than drinking, smoking: report
Cannabis is less harmful than alcohol or tobacco, according to a report by a British research charity Thursday, which called for a "serious rethink" of drug policy.
Medicinal marijuana effective for neuropathic pain in HIV
In a double-blind, placebo-controlled clinical trial to assess the impact of smoked medical cannabis, or marijuana, on the neuropathic pain associated with HIV, researchers at the University of California, San Diego School of Medicine found that reported pain relief was greater with cannabis than with a placebo. The study, sponsored by the University of California Center for Medical Cannabis Research (CMCR) based at UC San Diego, will be published on line, August 6 in the journal Neuropsychopharmacology.
Marijuana use on the rise among Ontario adults
While this CAMH Monitor eReport reveals some promising substance use trends among Ontario adults, its revelation of a substantial increase in cannabis use raises a significant public health flag.
Small study shows marijuana does not increase risk of head, neck cancer
Smoking marijuana (cannabis) does not increase the user’s risk of head and neck cancer, according to a new study published in the March 2008 issue of Otolaryngology – Head and Neck Surgery.
Cannabis indicated as possible risk for gum disease in young people
Young people who are heavy smokers of cannabis may be putting themselves at significant risk for periodontal disease, according to new research.

News discussion:

Medicine & Health news